Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis

Ying Luu, Wade Junker, Satyanarayana Rachagani, Srustidhar Das, Surinder Kumar Batra, Robert L. Heinrikson, Laurie L. Shekels, Samuel B. Ho

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and are thought to be cytoprotective. The extracellular regions of these mucins contain EGF-like Cys-rich segments (CRD1 and CRD2) connected by an intervening linker domain (L). The purpose of this study was to determine the functional activity of human MUC17 membrane-bound mucin. Methods: Endogenous MUC17 was inhibited in LS174T colon cells by stable transfection of a small hairpin RNA targeting MUC17 (LSsi cells). The effect of recombinant MUC17-CRD1-L-CRD2 protein on migration, apoptosis, and experimental colitis was determined. Results: Reduced MUC17 expression in LSsi cells was associated with visibly reduced cell aggregation, reduced cell-cell adherence, and reduced cell migration, but no change in tumorigenicity. LSsi cells also demonstrated a 3.7-fold increase in apoptosis rates compared with control cells following treatment with etoposide. Exposure of colonic cell lines to exogenous recombinant MUC17-CRD1-L-CRD2 protein significantly increased cell migration and inhibited apoptosis. As a marker of biologic activity, MUC17-CRD1-L-CRD2 proteins stimulate ERK phosphorylation in colonic cell lines; and inhibition of ERK phosphorylation reduced the anti-apoptosis and migratory effect of MUC17-CRD1-L-CRD2. Finally, mice treated with MUC17-CRD1-L-CRD2 protein given per rectum demonstrated accelerated healing in acetic acid and dextran sodium sulfate induced colitis in vivo. These data indicate that both native MUC17 and the exogenous recombinant cysteine-rich domain of MUC17 play a role in diverse cellular mechanisms related to cell restitution, and suggest a potential role for MUC17-CRD1-L-CRD2 recombinant protein in the treatment of mucosal inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)996-1006
Number of pages11
JournalInternational Journal of Biochemistry and Cell Biology
Volume42
Issue number6
DOIs
StatePublished - Jun 1 2010

Fingerprint

Mucins
Colitis
Apoptosis
Phosphorylation
Proteins
Cells
Membranes
Dextran Sulfate
Etoposide
Recombinant Proteins
Epidermal Growth Factor
Acetic Acid
Small Interfering RNA
Cell Movement
Cysteine
Agglomeration
Cell Line
Cell Aggregation
Intestinal Mucosa
Rectum

Keywords

  • Cell migration
  • Epidermal growth factor
  • Inflammatory bowel disease
  • MUC17
  • Mucin

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. / Luu, Ying; Junker, Wade; Rachagani, Satyanarayana; Das, Srustidhar; Batra, Surinder Kumar; Heinrikson, Robert L.; Shekels, Laurie L.; Ho, Samuel B.

In: International Journal of Biochemistry and Cell Biology, Vol. 42, No. 6, 01.06.2010, p. 996-1006.

Research output: Contribution to journalArticle

Luu, Ying ; Junker, Wade ; Rachagani, Satyanarayana ; Das, Srustidhar ; Batra, Surinder Kumar ; Heinrikson, Robert L. ; Shekels, Laurie L. ; Ho, Samuel B. / Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. In: International Journal of Biochemistry and Cell Biology. 2010 ; Vol. 42, No. 6. pp. 996-1006.
@article{e9bffd8439af41f284a40e9d744d0281,
title = "Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis",
abstract = "The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and are thought to be cytoprotective. The extracellular regions of these mucins contain EGF-like Cys-rich segments (CRD1 and CRD2) connected by an intervening linker domain (L). The purpose of this study was to determine the functional activity of human MUC17 membrane-bound mucin. Methods: Endogenous MUC17 was inhibited in LS174T colon cells by stable transfection of a small hairpin RNA targeting MUC17 (LSsi cells). The effect of recombinant MUC17-CRD1-L-CRD2 protein on migration, apoptosis, and experimental colitis was determined. Results: Reduced MUC17 expression in LSsi cells was associated with visibly reduced cell aggregation, reduced cell-cell adherence, and reduced cell migration, but no change in tumorigenicity. LSsi cells also demonstrated a 3.7-fold increase in apoptosis rates compared with control cells following treatment with etoposide. Exposure of colonic cell lines to exogenous recombinant MUC17-CRD1-L-CRD2 protein significantly increased cell migration and inhibited apoptosis. As a marker of biologic activity, MUC17-CRD1-L-CRD2 proteins stimulate ERK phosphorylation in colonic cell lines; and inhibition of ERK phosphorylation reduced the anti-apoptosis and migratory effect of MUC17-CRD1-L-CRD2. Finally, mice treated with MUC17-CRD1-L-CRD2 protein given per rectum demonstrated accelerated healing in acetic acid and dextran sodium sulfate induced colitis in vivo. These data indicate that both native MUC17 and the exogenous recombinant cysteine-rich domain of MUC17 play a role in diverse cellular mechanisms related to cell restitution, and suggest a potential role for MUC17-CRD1-L-CRD2 recombinant protein in the treatment of mucosal inflammatory diseases.",
keywords = "Cell migration, Epidermal growth factor, Inflammatory bowel disease, MUC17, Mucin",
author = "Ying Luu and Wade Junker and Satyanarayana Rachagani and Srustidhar Das and Batra, {Surinder Kumar} and Heinrikson, {Robert L.} and Shekels, {Laurie L.} and Ho, {Samuel B.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.biocel.2010.03.001",
language = "English (US)",
volume = "42",
pages = "996--1006",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis

AU - Luu, Ying

AU - Junker, Wade

AU - Rachagani, Satyanarayana

AU - Das, Srustidhar

AU - Batra, Surinder Kumar

AU - Heinrikson, Robert L.

AU - Shekels, Laurie L.

AU - Ho, Samuel B.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and are thought to be cytoprotective. The extracellular regions of these mucins contain EGF-like Cys-rich segments (CRD1 and CRD2) connected by an intervening linker domain (L). The purpose of this study was to determine the functional activity of human MUC17 membrane-bound mucin. Methods: Endogenous MUC17 was inhibited in LS174T colon cells by stable transfection of a small hairpin RNA targeting MUC17 (LSsi cells). The effect of recombinant MUC17-CRD1-L-CRD2 protein on migration, apoptosis, and experimental colitis was determined. Results: Reduced MUC17 expression in LSsi cells was associated with visibly reduced cell aggregation, reduced cell-cell adherence, and reduced cell migration, but no change in tumorigenicity. LSsi cells also demonstrated a 3.7-fold increase in apoptosis rates compared with control cells following treatment with etoposide. Exposure of colonic cell lines to exogenous recombinant MUC17-CRD1-L-CRD2 protein significantly increased cell migration and inhibited apoptosis. As a marker of biologic activity, MUC17-CRD1-L-CRD2 proteins stimulate ERK phosphorylation in colonic cell lines; and inhibition of ERK phosphorylation reduced the anti-apoptosis and migratory effect of MUC17-CRD1-L-CRD2. Finally, mice treated with MUC17-CRD1-L-CRD2 protein given per rectum demonstrated accelerated healing in acetic acid and dextran sodium sulfate induced colitis in vivo. These data indicate that both native MUC17 and the exogenous recombinant cysteine-rich domain of MUC17 play a role in diverse cellular mechanisms related to cell restitution, and suggest a potential role for MUC17-CRD1-L-CRD2 recombinant protein in the treatment of mucosal inflammatory diseases.

AB - The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and are thought to be cytoprotective. The extracellular regions of these mucins contain EGF-like Cys-rich segments (CRD1 and CRD2) connected by an intervening linker domain (L). The purpose of this study was to determine the functional activity of human MUC17 membrane-bound mucin. Methods: Endogenous MUC17 was inhibited in LS174T colon cells by stable transfection of a small hairpin RNA targeting MUC17 (LSsi cells). The effect of recombinant MUC17-CRD1-L-CRD2 protein on migration, apoptosis, and experimental colitis was determined. Results: Reduced MUC17 expression in LSsi cells was associated with visibly reduced cell aggregation, reduced cell-cell adherence, and reduced cell migration, but no change in tumorigenicity. LSsi cells also demonstrated a 3.7-fold increase in apoptosis rates compared with control cells following treatment with etoposide. Exposure of colonic cell lines to exogenous recombinant MUC17-CRD1-L-CRD2 protein significantly increased cell migration and inhibited apoptosis. As a marker of biologic activity, MUC17-CRD1-L-CRD2 proteins stimulate ERK phosphorylation in colonic cell lines; and inhibition of ERK phosphorylation reduced the anti-apoptosis and migratory effect of MUC17-CRD1-L-CRD2. Finally, mice treated with MUC17-CRD1-L-CRD2 protein given per rectum demonstrated accelerated healing in acetic acid and dextran sodium sulfate induced colitis in vivo. These data indicate that both native MUC17 and the exogenous recombinant cysteine-rich domain of MUC17 play a role in diverse cellular mechanisms related to cell restitution, and suggest a potential role for MUC17-CRD1-L-CRD2 recombinant protein in the treatment of mucosal inflammatory diseases.

KW - Cell migration

KW - Epidermal growth factor

KW - Inflammatory bowel disease

KW - MUC17

KW - Mucin

UR - http://www.scopus.com/inward/record.url?scp=77953809261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953809261&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2010.03.001

DO - 10.1016/j.biocel.2010.03.001

M3 - Article

C2 - 20211273

AN - SCOPUS:77953809261

VL - 42

SP - 996

EP - 1006

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 6

ER -